Occult Macular Dystrophy

Stephen H Tsang; Tarun Sharma

doi:10.1007/978-3-319-95046-4_19

Occult Macular Dystrophy

Adv Exp Med Biol. 2018:1085:103-104. doi: 10.1007/978-3-319-95046-4_19.

Authors

Stephen H Tsang^{1

2}, Tarun Sharma³

Affiliations

¹ Jonas Children's Vision Care, Bernard & Shirlee Brown Glaucoma Laboratory, Columbia Stem Cell Initiative-Departments of Ophthalmology, Biomedical Engineering, Pathology & Cell Biology, Institute of Human Nutrition, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.
² Department of Ophthalmology, Columbia University, Edward S. Harkness Eye Institute, NewYork-Presbyterian Hospital, New York, NY, USA.
³ Department of Ophthalmology, Columbia University, Edward S. Harkness Eye Institute, NewYork-Presbyterian Hospital, New York, NY, USA. [email protected].

PMID: 30578492
DOI: 10.1007/978-3-319-95046-4_19

Abstract

Patients with occult macular dystrophy (OMD) are usually middle-aged and have progressive loss of central vision or notice central scotoma, but no significant abnormality is seen in the fundus or fluorescein angiography. Optical coherence tomography (OCT) shows loss of the ellipsoid band in the central area (Fig. 19.1). Full-field electroretinography (ERG) is normal or may show diminished cone response; multifocal ERG reveals diminished amplitude in the central retina.

Keywords: Autosomal dominant; Occult macular dystrophy.

Publication types

Review

MeSH terms

Electroretinography
Fluorescein Angiography
Humans
Macular Degeneration / physiopathology*
Tomography, Optical Coherence